YAP1 and cancer: Bulk RNA-Seq analysis revealed that the ECM-related gene signatures were reduced when Yap1 was silenced (Figure 4B), indicating that the cancer-derived YAP signaling not only acts as a downstream effector of HA but also promotes CAF activity to regulate a fibrotic TME.